RxDoctor Payments Data

William Currie, MD

Family Medicine · Ellisville, MSNPI 1518378116

Payments from drug & device makers

$1,259in general payments, 2019–2025

Across 75 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$426
  • Novo Nordisk$204
  • Lilly USA, LLC$191
  • Boehringer Ingelheim$120
  • AstraZeneca$113
  • Amgen$72
  • plus $132 from 6 others

What the payments were for

  • Food & beverage$1,259100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,259 in reported general payments places this provider in the 60th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$178,149
Medicare patients
288
Services billed
3,335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide143$211,358
MounjaroTirzepatide82$120,814
JardianceEmpagliflozin66$81,240
XareltoRivaroxaban33$34,879
Tresiba Flextouch U-100Insulin Degludec39$30,644
EliquisApixaban27$23,527
LinzessLinaclotide23$18,286
Tresiba Flextouch U-200Insulin Degludec22$16,603
FarxigaDapagliflozin Propanediol20$14,138
Synjardy XrEmpagliflozin/Metformin Hcl16$11,445
ShingrixVaricella-Zoster Ge/As01b/Pf45$10,140
TradjentaLinagliptin16$8,038
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide165$5,611
Valsartan155$4,322
Rosuvastatin Calcium387$4,061

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$204$211,358143 claims
Lilly USA, LLCMounjaro$191$120,81482 claims
Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta$120$100,72398 claims
AbbVieLinzess, Synthroid$426$21,66176 claims
AstraZenecaFarxiga$113$14,13820 claims
GSKShingrix$14$10,14045 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Ellisville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →